Backlog review results drag Elekta shares lower

Elekta AB (publ)

10/06/2025 11:23

** Shares in Elekta EKTAb.ST are down nearly 5%, paring earlier losses of as much as 9.6%, after the Swedish med-tech company announced outcome of order evaluation

** The review led to cancellation valued at SEK 4.9 billion ($510.87 million) and new backlog standing at SEK 36.9 billion

** Danske Bank analyst notes that new backlog is 17% lower than most recently reported figure

** Elekta, which earlier on Tuesday announced the appointment of Jakob Just-Bomholt as its new president and CEO, kept the group's mid-term EBIT margin target of at least 14% unchanged

** Jeffries views Just-Bomholt's nomination, the former CEO of the successful dental company 3Shape, positively, but notes that Elekta's mixed execution record will likely remain a concern in the short term

** The stock, on track for its worst day in two months, is among worst STOXX 600 .STOXX performers

($1 = 9.5914 Swedish crowns)

 (Reporting by Anna Chaberska)

 ((Anna.chaberska@thomsonreuters.com;))